SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Myriad Genetics, Inc. (MYGN) -- Ignore unavailable to you. Want to Upgrade?


To: A.J. Mullen who wrote (21)8/4/1998 9:24:00 PM
From: flanew  Read Replies (1) | Respond to of 2355
 
Aetna deal confirms future for genetic testing
Deal will add strength to future cash flow, but more important confirms the added benefit for Insurance co to reduce future cost,by early treatment of diseases.Impressed by the scope of percentage to total insured Americans. Which insurance co will be next?